Covered recipient · General Payments record
STEPHANIE M JOHNSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2025
$5,766.78
- Reported across 290 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,455.16 | 70 |
| Education | $83.99 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $226.28 | 12 |
| Janssen Biotech, Inc. | $129.96 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $121.63 | 5 |
| CATALYST PHARMACEUTICALS, INC. | $96.67 | 4 |
| UCB, Inc. | $91.41 | 4 |
| ARGENX US, INC. | $91.03 | 5 |
| Genentech USA, Inc. | $90.89 | 4 |
| Amgen Inc. | $78.42 | 3 |
| TG THERAPEUTICS, INC. | $61.99 | 4 |
| CSL Behring | $52.54 | 3 |
| EISAI INC. | $48.17 | 2 |
| Neurelis, Inc. | $45.88 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.84 | 2 |
| Lilly USA, LLC | $30.21 | 1 |
| SpringWorks Therapeutics, Inc. | $29.05 | 1 |
| Alnylam Pharmaceuticals Inc. | $24.90 | 1 |
| ACADIA Pharmaceuticals Inc | $24.05 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.70 | 1 |
| JAZZ PHARMACEUTICALS INC. | $22.41 | 1 |
| Celgene Corporation | $22.26 | 1 |
| Vanda Pharmaceuticals Inc. | $21.21 | 1 |
| Supernus Pharmaceuticals, Inc. | $20.83 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.76 | 1 |
| SK Life Science, Inc. | $20.17 | 1 |
| Averitas Pharma Inc. | $19.34 | 1 |
| EMD Serono, Inc. | $18.77 | 1 |
| PFIZER INC. | $17.15 | 1 |
| Abbott Laboratories | $16.26 | 1 |
| CHIESI USA, INC. | $16.17 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (71)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.